New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
11:33 EDTAPOL, SVU, INFY, MU, PCYCOptions with decreasing implied volatility: APOL SVU INFY MU PCYC
News For APOL;SVU;INFY;MU;PCYC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 16, 2014
14:47 EDTMUEarnings Preview: Pacific Crest, RBC positive on SanDisk ahead of report
Subscribe for More Information
10:42 EDTSVUSupervalu expects to see improvements in back-half of year
Subscribe for More Information
10:37 EDTSVUSupervalu expects margins to improve as company moves to Q3, Q4
Subscribe for More Information
10:04 EDTSVUSupervalu says expectations for full-year have not changed
Subscribe for More Information
08:05 EDTSVUSupervalu reports Q2 adjusted EPS 11c, consensus 11c
Subscribe for More Information
October 15, 2014
12:03 EDTINFYInfosys says no investments made in Ooyala, Clique Intelligence.
Subscribe for More Information
11:27 EDTINFYOptions with decreasing implied volatility
Options with decreasing implied volatility: EXAS INO ATLS LOCO OPK INFY EUO FDO
10:02 EDTMUOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:07 EDTAPOLFor profit education positive catalysts outweigh negative, says Wells Fargo
Wells Fargo expects for-profit education stocks to benefit from improved hiring trends and a sale by Corinthian of its assets that, according t othe firm ,would set a valuation floor for the sector. The firm continues to believe that the final gainful employment rule will be neutral to positive for the group. Wells favors the option value on the long side for the sector. Publicly traded companies in the space include American Public Education (APEI), Apollo Education (APOL), Bridgepoint Education (BPI), Career Education (CECO), Corinthian Colleges (COCO), DeVry (DV), Grand Canyon (LOPE), ITT Educational (ESI) and Strayer (STRA).
06:19 EDTMUMicron upgraded to Overweight from Neutral at JPMorgan
Subscribe for More Information
06:16 EDTPCYCPharmacyclics initiated with a Buy at Citigroup
Subscribe for More Information
October 14, 2014
11:17 EDTINFYOptions with decreasing implied volatility
Subscribe for More Information
October 13, 2014
12:01 EDTINFYOptions with decreasing implied volatility
Options with decreasing implied volatility: EXAS INFY YUM FDO HSY
10:26 EDTINFYHigh option volume stocks
Subscribe for More Information
10:08 EDTINFYOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:05 EDTPCYCBristol-Myers, Pharmacyclics, Janssen announce clinical collaboration
Bristol-Myers Squibb Company (BMY), Pharmacyclics, Inc. (PCYC), and Janssen Research & Development, LLC (JNJ) announced today they have entered into a clinical trial collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of Bristol-Myers Squibb’s investigational PD-1 immune checkpoint inhibitor OPDIVO in combination with IMBRUVICA, an oral Bruton's tyrosine kinase inhibitor co-developed and co-marketed by Pharmacyclics and Janssen. The Phase 1/2 study will focus on evaluating the safety and anti-tumor activity of combining OPDIVO and IMBRUVICA as a potential treatment option for patients with non-Hodgkin lymphoma, including diffuse large B-cell lymphoma, follicular lymphoma and chronic lymphocytic leukemia. Bristol-Myers Squibb has proposed the name OPDIVO, which if approved by health authorities, will serve as the trademark for the investigational drug, nivolumab. OPDIVO is part of a new class of cancer treatments known as immunotherapies, which are designed to harness the body’s own immune system in fighting cancer by targeting distinct regulatory components of the immune system. Each agent has individually shown activity against hematologic malignancies in clinical trials; pre-clinical evidence suggests OPDIVO and IMBRUVICA may have the potential for additive treatment effects in patients with hematologic malignancies. The study will be conducted by Janssen. Additional details of the collaboration were not disclosed.
07:51 EDTINFYInfosys upgraded to Buy from Hold at Deutsche Bank
Subscribe for More Information
06:11 EDTINFYInfosys upgraded to Buy from Hold at Deutsche Bank
06:03 EDTMUStocks with implied volatility above IV index mean; HTZ MU
Subscribe for More Information
October 12, 2014
17:58 EDTMUMicron shares look more attractive, Barron's says
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use